AmerisourceBergen Corp. (ABC) is Reiterated by RBC Capital Mkts to Outperform, Lowers Price Target to $ 85

AmerisourceBergen Corp. (ABC) was Reiterated by RBC Capital Mkts to “Outperform” while Lowering the Price Target of the company shares to $ 85 from a previous price target of $100 . RBC Capital Mkts advised their investors in a research report released on May 6, 2016.

Many Wall Street Analysts have commented on AmerisourceBergen Corp.. Shares were Reiterated by FBR Capital on May 6, 2016 to “Mkt Perform” and Lowered the Price Target to $ 84 from a previous price target of $100 .AmerisourceBergen Corp. was Downgraded by Avondale to ” Mkt Perform” on May 5, 2016. Avondale Initiated AmerisourceBergen Corp. on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.

On the company’s financial health, AmerisourceBergen Corp. reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on May 5, 2016. Analyst had a consensus of $1.58. The company had revenue of $35698.36 million for the quarter, compared to analysts expectations of $35804.35 million. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.45 EPS.

In a different news, on Mar 3, 2016, Dale Danilewitz (Executive Vice President) sold 1,586 shares at $86.80 per share price. According to the SEC, on Dec 22, 2015, Steven H Collis (President & CEO) sold 27,148 shares at $102.23 per share price. On Dec 2, 2015, Dermot Mark Durcan (director) purchased 1,000 shares at $99.70 per share price, according to the Form-4 filing with the securities and exchange commission.

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company operates through two segments: Pharmaceutical Distribution and Other. The Company also provides data and other services to its manufacturing customers. The Company provides services to healthcare providers and pharmaceutical and biotech manufacturers. The Company provides pharmacy services to certain specialty drug patients. Additionally the Company offers healthcare providers and pharmaceutical manufacturers with services including reimbursement and pharmaceutical consulting services logistics services inventory management pharmacy automation and pharmacy management. The Company has a distribution facility network totaling approximately 30 distribution facilities in the United States.

AmerisourceBergen Corp.

Leave a Reply

AmerisourceBergen Corp. - Is it time to Sell?

Top Brokerage Firms are advising their investors on AmerisourceBergen Corp.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.